Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Livzon Pharmaceutical Group Inc

+ Add to Watchlist

000513:CH

84.500 CNY 0.560 0.66%

As of 03:00:26 ET on 05/29/2015.

Snapshot for Livzon Pharmaceutical Group Inc (000513)

Open: 83.940 Day's Range: 80.100 - 87.290 Volume: 4,090,014
Previous Close: 85.060 52wk Range: 44.770 - 99.430 1-Yr Rtn: +88.11%

Stock Chart for 000513

No chart data available.
  • 000513:CH 84.500
  • 1D
  • 1M
  • 1Y
85.060
Interactive 000513 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 000513

Current P/E Ratio (ttm) 44.8880
Estimated P/E(12/2015) 39.4307
Relative P/E vs. SZASHR 0.6490
Earnings Per Share (CNY) (ttm) 1.8825
Est. EPS (CNY) (12/2015) 2.1430
Est. PEG Ratio -
Market Cap (M CNY) 22,123.27
Shares Outstanding (M) 192.39
30 Day Average Volume 4,264,719
Price/Book (mrq) 6.2578
Price/Sale (ttm) 4.3278
Dividend Indicated Gross Yield 0.12%
Cash Dividend (CNY) 0.1000
Dividend Ex-Date
5 Year Dividend Growth 27.23%
Next Earnings Announcement 08/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 000513

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 000513

Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.

Tao DeshengPresidentYang DaihongVice President
Lu WenqiVice PresidentXu GuoxiangVice President
More Company Profile & Key Executives for 000513

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil